Image provided by: Texas A&M University
About The Battalion. (College Station, Tex.) 1893-current | View Entire Issue (April 7, 1994)
DEFENSIVE DRIVING CLASS 6 HOUR COURSE $17 or $15 with A&M I.D. Wednesday, April 13 (6-9 pm) Thursday, April 14 (6-9 pm) Saturday, April 23 (8:30-11:30 am & 12:30-3:30 pm) TICKET DISMISSAL - INSURANCE DISCOUNT MSC UNIVERSITY PLUS 845-1631 Page 10 The Battalion Thursday, ApriP.ffii On the go! WILEY L E C T U RE SERIES Memorial Student (Center'" ^ April 8, 1994, 8:00 p.m. / Rudder Auditorium Texas A&M University N ^ / X, Mr. Les Aspin Former U.S. Secretary of N Defense Mr. William F. Buckley. Jr. Moderator Some say\the U.S. is no longer in a position to be the world's policeman. President Clinton has attempted to redefine U.S. involvement in the international community. Kirkpatrick and Aspin will exatnine both sides of this controversial issue. Tickets available at the MSC Box Office, oir"call 845-1234. Juror skips trial for work, faces $5,000 fine, jail time Thursday The Associated Press Rad listei apai bun Jennie Mayer/77;<■ Battalion David Conley, a visitor to the A&M campus, practices in Research Park on Wednesday. FORT WORTH — A Chico man says he was putting his family first when he de cided to show up for the first day of a new job rather than jury duty. Now, he faces a possible $5,000 fine and six months in federal prison for con tempt of court. Brian Clampitt, 23, was selected last week to hear a drug trial in the court room of U.S. District Judge Terry Means. On Thursday, the jury began its delib erations and then recessed for a long East er weekend. But Monday morning, Clampitt did not return to jury duty. Instead he went to work. Clampitt said he felt he would not be hired if he did not show up for his first day of work at Jim’s Oilfield Service. He said bills were stacking up at home and that the new job would help his wife, a waitress, and their 2-year-old daughter. He said he finally decided, “You have to put your family first.” A woman who identified herself as Clampitt’s wife called the U.S. District Clerk’s Office and said Clampitt was sick and unable to appear for further jury duty, federal officials said. The clerk was told Clampitt was so ill The Asso pFORT .,tion say: listener; bidden i in shaml I An ai lountry based ii that the family was going to ukei phone receiver off the hook. The . judge became suspicious andk his staff to start making calls. Clamf was finally tracked down at his new jolt h > “(Means) just told me I’d betterr.t;| ; J- 31156 to Fort Worth pretty quickly,” Clajiipi:^” rar ^ a said. “I even got a speeding ticket te I down there.” Clampitt joined the rest of the juj Monday. After four hours of deliberatio jurors found the three defendants gui of drug-related charges. Means called Clampitt to the bencM ter dismissing the other jurors. “He just told me that the choice Inn was a very serious mistake,’’ Clampittst; Clampitt is scheduled to appear be the judge next Monday. He said he has mixed emotions al what his punishment should be. “1 think it would be about rightl them to put me in jail, since I didn’tsb up in court and it could have meantle ting drug dealers walk the streets, Clampitt said. But he said people get probation for cl sorts of serious crimes. ^ ,,, It 1 ‘You I tie abor .. libraries dollars 1 tivate i brary,” [ The than 8 brought clay, rip and the floor, s arsha “Heck, here they want to put mein for trying to support my family,” he i| the Fort Worth Star-Telegram. Heliskiers risk danger as part of thrill The Associated Press RENO, Nev. — They ski moun- taintops so.remote that they need a helicopter to get there. They shun groomed slopes for virgin powder, crowds for thrills and scenery. When the day ends, the only tracks on the mountain will be the miles of lines they have left behind. For heliskiers, it’s the ultimate adventure. Some end up paying the ultimate price. The sport is expensive. Like mountain climbing or whitewater rafting, death is n£ver far away. On Sunday, Walt Disney Co. President Frank Wells was return ing from a heliskiing trip in the Ruby Mountains 25 miles south west of Elko, Nev., when the chop per crashed into a steep canyon. Wells, a fellow passenger and the pilot were killed. Two others were seriously injured. Two days earlier, model Christie Brinkley and four others were in jured when their chopper went down after a trip near Telluride, Colo. They were stranded for about six hours. A copter crash in January 1993 killed four people, including Brent Patterson, who owned Diamond Peak Heli-Ski Adventures near Og den, Utah. “There’s inherent hazards in this activity. This is an adventure sport,’’ said Greg Smith, owner and founder of Wasatch Powerbird Guides in Snowbird, Utah. “It’s a thrilling activity, but there’s more risk involved in doing it than sitting aMiome reading about it. This is a very uncon trolled environment.’^ About 62,000 heliski trips are made each year in North America. They can cost as little as $450 for a day or more than $ 1,650 for a three-day trip. “It’s the difference between gourmet dining and fast food,” said Ross McGaw, marketing direc tor at Mountain Helisports near Whistler, British Columbia. “It is a rush being around the helicopter lifting you up to run after run of untracked beautiful powder snow. It’s something you can never get tired of.” The inviting powder also can be a peril. A skier can unknowingly plunge into a drift-filled bowl and suffocate. Mountain storms can move in with vicious winds, blind ing snow and bitter cold. Most of the skiing is in avalanche zones. Three years ago, an avalanche swept nine heliskiers to their deaths in the Purcell Mountains, some 400 miles east of Whistler. Trained guides pick thesafesti ing areas, away from knows avalanche danger. They watch I weather and screen skiers for abifc “Route finding, terrain seleo tion, good guiding can redoti the avalanche danger,” Smi said. “But this is not an exactsc ence. That danger cannot be 10 tally eliminated. ’ Skiers are placed in approprir ability groups, he said, and sora below intermediate level an turned back. “We’ve picked up people iniks morning reeking of marijuana we have to say no,” McGaw said “We’ve got to protect theraselve and ourselves, and other peopi: because people are stupid some times.” Smith and 'McGa'xV say death and injuries among helisidbY/zr no higher than on the ski slopes in and [the she! And 'climb on eacb pie in t Liste that the 10,00 the DJ “W we ne said, for the pened. He dio sta facials “It inspir; he doe 40 pec leave,’ No made. severa return As brary . up ab floor, I COLLEGE PREGNANCIES PRESSURES *■ . * ■ OPTIONS COMMUNITY RESPONSIBILITY A panel discussion featuring representatives from the Department of Psychology and the Student Counseling Center on dealing with the stresses associated with unexpected college pregnancies. Harrington 108 Thursday, April 7 7:00 p.m. presented by DepoProvera® Contraceptive Injection (sterile medroxyprogesterone acetate suspension, USP) WHAT IS DEPO-PROVERA CONTRACEPTIVE INJECTION? DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an intra muscular injection (a shot) in the buttock or upper arm once every 3 months. To continue your contraceptive protection, you must return for your next injection promptly at the end of 3 months. DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your egg cells from ripening. If an egg is not released from the ovaries during your menstrual cycle, it cannot become fertilized by sperm and result In pregnancy. DEPO-PROVERA also causes changes in the lining of your uterus that make it less likely for pregnancy to occur. HOW EFFECTIVE IS DEPO-PROVERA CONTRACEPTIVE INJECTION? DEPO-PROVERA is over 99% effective, making it one of the most reliable methods of birth control available. This means that the average annual pregnancy rate is less than one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive methods depends in part on how reliably each woman uses the method. The effectiveness of DEPO-PROVERA depends only on the patient returning every 3 months for her next injection. Your health-care provider will help you compare DEPO-PROVERA with other con traceptive methods and give you the information you need in order to decide which contra ceptive method is the right choice for you. The following table shows the percent of women who got pregnant while using different kinds of contraceptive methods. It gives both the lowest expected rate of pregancy (the rate expected in women who use each method exactly as it should be used) and the typical rate of pregnancy (which includes women who became pregnant because they forgot to use their birth control or because they did not follow the directions exactly). PERCENT OF WOMEN EXPERIENCING AN ACCIDENTAL PREGNANCY IN THE FIRST YEAR OF CONTINUOUS USE Method Lowest Expected Typical DEPO-PROVERA 0.3 0.3 Implants (Norplant®) 0.3 0.3 Female sterilization 0.2 0.4 Male sterilization 0.1 0.15 Oral contraceptive (pill) V 3 Combined 0.1 Progestogen only 0.5 - IUD 3 Proqestasert 2.0 Copper T 380A 0.8 - Condom (without spermicide) 2 12 Diaphragm (with spermicide) 6 18 Cervical Cap 6 18 Withdrawal 4 18 Periodic abstinence 1 - 9 20 Spermicide alone 3 21 Vaginal Sponge Used before childbirth 6 18 Used after childbirth 9 28 No method 85 85 Source: Trussell et al; Obstet Gyncol 76:558, 1990 WHO SHOULD NOT USE DEPO-PROVERA CONTRACEPTIVE INJECTION? Not all women should use DEPO-PROVERA. You should not use DEPO-PROVERA if you think you might be pregnant, have any vaginal bleeding without a known reason, have had cancer of the breast, have had a stroke, have or have had blood clots (phlebitis) in your legs, have problems with your liver or liver disease, or are allergic to DEPO- PROVERA (medroxyprogesterone acetate or any of its other ingredients). You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is important to tell your doctor if you are taking any prescription or over-the-counter medications or if you have a'family history of breast cancer; an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples; kidney disease; irregular or scanty menstrual periods; high blood pressure; migraine headaches; asthma; epilepsy (convulsions or seizures); diabetes or a family history of diabetes; or a history of depression. WHAT IF I WANT TO BECOME PREGNANT AFTER USING DEPO-PROVERA CONTRACEPTIVE INJECTION? Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last injection for its effect to wear off. Based on the results from a large study done in the United States, for women who stop using DEPO-PROVERA in order to become preg nant, it is expected that about half of those who become pregnant will do so in about 10 months after their last injection; about two thirds of those who become pregnant will do so in about 12 months; about 83% of those who become pregnant will do so in about 15 months; and about 93% of those who become pregnant will do so in about 18 months after their last injection. The length of time you use DEPO-PROVERA has no effect on how long it takes you to become pregnant after you stop using it. WHAT ARE THE RISKS OF USING DEPO-PROVERA CONTRACEPTIVE INJECTION? 1. Irregular Menstrua! Bleeding The side effect reported most frequently by women who use DEPO-PROVERA for contra ception is a change in their normal menstrual cycle. During the first year of using DEPO- PROVERA, you might have one or more of the following changes: Irregular or unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding at all. Unusually heavy or continuous bleeding, however, is not a usual effect of DEPO-PROVERA, and if this happens, you should see your health-care provider right away. With continued use of DEPO-PROVERA, bleeding usually decreases, and many women stop having peri ods completely. In clinical studies of DEPO-PROVERA, 57% of the women studied report ed no menstrual bleeding (amenorrhea) after 1 year of use, and 68% of the women studied reported no menstrual bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the regular monthly growth of the lining of your uterus does not occur and, therefore, the bleeding that comes with your normal menstruation does not take place. When you stop using DEPO-PROVERA your menstrual period will usually, in time, return to its normal cycle. 2. Bone Mineral Changes Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in your bones. This could increase your risk of developing bone fractures. The rate of bone mineral loss is greatest In the early years of DEPO-PROVERA use, but after that, it begins to resemble the normal rate of age-related bone mineral loss. 3. Cancer Studies of women who have used different forms of contraception found that women who used DEPO-PROVERA for contraception had no increased overall risk of developing cancer of the breast, ovaiy, uterus, cervix, or liver. However, women under 35 years of age whose first exposure to DEPO-PROVERA was within the previous 4 years may have a slightly increased risk of developing breast cancer similar to that seen with oral contraceptives. You should discuss this with your health-care provider. 4. Accidental Pregnancy Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental pregnancy for women who get their shots regularly (every 3 months) is very low. While there have been reports of an increased risk of low birth weight and neonatal infant death or other health problems in infants conceived close to the time of injection, such pregnancies are rare. If you think you may have become pregnant while using DEPO-PROVERA for con traception, see your health-care provider as soon as possible. 5. Other Risks Women who use hormone-based contraceptives may have an increased risk of blood clots or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should tell your health-care provider if you have any of the problems listed in the next section. WHAT SYMPTOMS MAY SIGNAL PROBLEMS WHILE USING DEPO-PROVERA CONTRACEPTIVE INJECTION? Call your health-care provider immediately if any of these problems occur following an injection of DEPO-PROVERA: Sharp chest pain, coughing of blood, or sudden shortness of breath (indicating a possible clot in the lung); sudden severe headache or vomiting, dizzi ness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm or leg (indicating a possible stroke); severe pain or swelling in the calf (indicating a possible clot in the leg); unusually heavy vaginal bleeding; severe pain or tenderness in the lower abdominal area; or persistent pain, pus, or bleeding at the injection site. WHAT ARE THE POSSIBLE SIDE EFFECTS OF DEPO-PROVERA CONTRACEPTIVE INJECTION? 1. Weight Gain You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds during the first year of use. You may continue to gain weight after the first year. Women in one large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over those 2 years, or approximately 4 pounds per year. Women who contin ued for 4 years gained an average total of 13.8 pounds over those 4 years, or approximate ly 3.5 pounds per year. Women who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or approximately 2.75 pounds per year. 2. Other Side Effects In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some women reported the following effects that may or may not have been related to their use of DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal discharge or irritation, breast swelling and tenderness, bloating, swelling of the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, and hot flashes. Other problems were reported by very few of the women in the clinical trials, but some of these could be serious. These include convulsions, jaundice, urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer, or cervical can cer. If these or any other problems occur during your use of DEPO-PROVERA, discuss them with your health-care provider. SHOULD ANY PRECAUTIONS BE FOLLOWED DURING USE OF DEPO-PROVERA CONTRACEPTIVE INJECTION? 1. Missed Periods During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your periods may stop completely. If you have been receiving your DEPO-PROVERA injections regularly every 3 months, then you are probably not pregnant. However, if you think that you may be pregnant, see your health-care provider. 2. Laboratory Test Interactions If you are scheduled for any laboratory tests, tell your health-care provider that you are using DEPO-PROVERA for contraception. Certain blood tests are affected by hormones such as DEPO-PROVERA. 3. Drug Interactions Cytadren (aminoglutethimide) is an anticancer drug that may significantly decrease the effectiveness of DEPO-PROVERA if the two drugs are given during the same time. 4. Nursing Mothers Although DEPO-PROVERA can be passed to the nursing infant in the breast milk, no harm ful effects have been found in these children. DEPO-PROVERA does not prevent the breasts from producing milk, so it can be used by nursing mothers. However, to minimize the amount of DEPO-PROVERA that is passed to the infant in the first weeks after birth, you should wait until 6 weeks after childbirth before you start using DEPO-PROVERA for contraception. HOW OFTEN DO I GET MY SHOT OF DEPO-PROVERA CONTRACEPTIVE INJECTION? The recommended dose of DEPO-PROVERA is 150 mg every 3 months given in a single intramuscular injection in the buttock or upper arm. To make sure that you are not pregnant at the time of the first injection, it is important that the injection be given only during the first 5 days after the beginning of a normal menstrual period. If used following the delivery of a child, the first injection of DEPO-PROVERA should be given within 5 days after childbirth if you are not breast-feeding or 6 weeks after childbirth if you are breast-feeding. If you wait longer than 3 months between injections, or longer than 6 weeks after childbirth, your health-care provider should determine that you are not pregnant before giving you your injection of DEPO-PROVERA. Caution: Federal law prohibits dispensing without a prescription. You must see a doctor to receive a prescription. Upjohn The Upjohn Company Kalamazoo, Ml 49001, USA CB-2-S USJ 9529.00 <5